A Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)
NCT00554385
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
283
Enrollment
INDUSTRY
Sponsor class
Conditions
Attention-Deficit/Hyperactivity Disorder
Interventions
DRUG:
ABT-089
Sponsor
Abbott